Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.472 | Molecular anaylsis of plasma DNA of nasopharyngeal carcinoma patients | Prof. CHAN Allen Kwan Chee |
| 2009.128 | Development of Thermo-regulated Pressure Therapy Gloves Used for Burn Rehabilitation | Ms. CHAN Amelia Ying Fan |
| 2018.467 | Finite Element Model for Design of Pressure Therapy Gloves for Hypertrophic Scars |
Ms. CHAN Amelia Ying Fan 陳映芬 |
| 2023.106 | Time-to-event machine learning model for predicating malignant transformation of oral lichenoid conditions: a multicenter cohort study | Dr. CHAN Amy Bik Wan |
| 2022.434 | Evaluation of a program for routine implementation of symptom distress screening and referral in cancer care: a stepped wedge cluster randomized trial |
Ms. CHAN Angela Chung Sze 陳頌詩 |
| 2018.089 | Chinese translation and cross-cultural adaption of the return-to-work self-efficacy (RTWSE-19) scale among Chinese female breast cancer survivors in Hong Kong |
Ms CHAN Angela Chung Sze 陳頌詩 |
| 2021.538 | A longitudinal study of the impact of sexual self-concept on sexual functioning and sexual quality of life (QOL) among breast cancer survivors | Ms. CHAN Angela Chung Sze |
| 2022.470 | Study of fusion negative dermatofibrosarcoma protuberans | Dr. CHAN Angela Zaneta |
| 2020.441 | Underestimation Rates of Atypical Ductal Hyperplasia and Ductal Carcinoma In-Situ Diagnosed with Stereotactic Guided Vacuum Assisted Biopsy | Dr. CHAN Angie Lok Chi |
| 2013.305 | Percutaneous Left Atrial Appendage Closure by LAmbre device for Stroke Prevention in High-risk Atrial Fibrillation | Dr. CHAN Anna Kin Yin |
| 2015.249 | AMPLATZER™ Amulet™ Observational Post-Market Study |
Dr. CHAN Anna Kin Yin 陳堅燕 |
| 2015.013 | Percutaneous edge-to-edge repair for severe mitral regurgitation patients who are not candidates for open heart surgery | Dr. CHAN Anna Kin Yin |
| 2018.040 | Mediating the relationship between pain intensity and adjustment in chronic pain: comparison between the roles of cognitive behavioural-based and contextual behavioural-based factors |
Dr. CHAN Anne Miu Han 陳妙嫻 |
| 2015.084 | Effects of combined repetitive transcranial magnetic stimulation and treadmill training on gait performance in Parkinson’s disease – a randomised controlled trial |
Dr. CHAN Anne Y.Y. 陳然欣 |
| 2012.511 | Identification of novel gene mutations that cause dominant spinocerebellar ataxias in Hong Kong | Dr. CHAN Anne Y.Y. |
| 2012.361 | Establishment of genetic basis for neurological disease by genetic screening and development of disease-specific induced pluripotent stem (iPS) cells from dermal fibroblasts in selected patients | Dr. CHAN Anne Y.Y. |
| 2012.364 | Hong Kong Spinocerebellar Ataxias Registry | Dr. CHAN Anne Y.Y. |
| 2014.420 | Physiotherapy ambulation training protocol for people with Parkinson's disease | Dr. CHAN Anne Yin Yan |
| 2013.602 | Reliability and Validity of the Chinese Version of the Unified Parkinson's Disease Rating Scale (UPDRS) in Patients with Parkinson's Diseases | Dr. CHAN Anne YY |
| 2012.028 | Identification of biomarkers of response and resistance to anti-angiogenic agents in nasopharyngeal cancer | Prof Chan Anthony |
| 2012.268 | META-ANALYSIS OF CHEMOTHERAPY IN NASO-PHARYNX CARCINOMA - An update with trials up to 2010 | Professor Chan Anthony |
| 2010.597 | Towards personalized cancer therapy: Single nucleotide polymorphisms of the DNA repair protein, Excision Repair Cross Complementation group 1 (ERCC1), in Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2008.559 | Elucidating the role of the metastasis-associated SLBLING protein osteopontin in nasopharyngeal cancer | Prof Chan Anthony |
| 2010.253 | Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2005.414 | A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin | Prof. CHAN Anthony |
| 2008.203 | Phase II Study of TAS-106 in Patients with Recurrent or Metastatic Head and Neck Cancer Refractory to Platinum Based Chemotherapy | Prof. Chan Anthony |
| 2006.256 | Randomized Trial to Evaluate the Therapeutic Gain by Changing the Chemoradiotherapy from Concurrent-Adjuvant to Induction-Concurrent Sequence, and the Radiotherapy from Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2008.084 | Efficacy of Recombinant Epstein-Barr virus (EBV) Vaccine in Patients with Nasopharyngeal Cancer who had Residual EBV DNA Load after Conventional Therapy | Prof. CHAN Anthony |
| 2016.472 | POOL-ANALYSIS OF INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA |
Prof. CHAN Anthony 陳德章 |
| 2014.408 | Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) | Prof. CHAN Anthony |
| 2006.024 | A Phase I Trial of 5-Azacitidine and Suberoylanilide Hydroxamic Acid in Patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma | Prof. CHAN Anthony T. C. |
| 2007.198 | A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer | Prof. CHAN Anthony T. C. |
| 2008.198 | A Phase 2, Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Prof. CHAN Anthony T.C. |
| 2000.447 | Pre and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases from Colorectal Origin Phase III Randomized Study | Prof. CHAN Anthony T.C. |
| 2009.572 | Clinical significance of the metastasis-associated protein osteopontin in naopharyngeal cancer | Prof. Chan Anthony T.C. |
| 2019.001 | Survival analysis of germline polymorphism and prognosis of patients with NPC |
Prof. CHAN Anthony T.C. 陳德章 |
| 2018.372 | NEO-SPACE trial: Neoadjuvant Pembrolizumab-Gemcitabine-Cisplatin followed by Concurrent Pembrolizumab-Chemoradiation and Maintenance Pembrolizumab for Stage IVA Nasopharyngeal Cancer |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2019.553 | AXEL: Axitinib-Avelumab combination in recurrent or metastatic nasopharyngeal cancer: a multicenter phase 2 trial |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2010.396 | A Proposed Histological Classification of Nasopharyngeal Carcinoma Based on Epithelial-Messenchymal Transition and Its Significance in Prognosis Prediction | Prof. Chan Anthony Tak Cheung |
| 2013.295 | LUX-Head & Neck 3: A randomized, open label, phase III study to evaluate the efficacy and safety of oral afatinib (BIBW 2992) versus intravenous methotrexate in patients with recurrent and / or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy. | Prof. CHAN Anthony Tak Cheung |
| 2016.070 | A Two-arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122) |
Prof. CHAN Anthony Tak Cheung 陳德章敎授 |
| 2016.382 | Detection and isolation of circulating tumor cells from patients with nasopharyngeal carcinoma. |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2014.409 | An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Prof. CHAN Anthony Tak Cheung |
| 2004.024 | Identification of Serum Prognostic Proteomic Patterns in Nasopharyngeal Carcinoma Development of Clinical Assay Prototype with the Combined Use of SELDI-TOF Mass Spectrometry and Bioinformatic Analyses | Prof. CHAN Anthony TC |
| 2026.228 | The "False-High" Transferrin Saturation Phenotype: A Retrospective Review of Elevated TSAT Caused by Hypotransferrinaemia in Maintenance Haemodialysis Patients in Hong Kong. | Dr. CHAN Anthony Ting Pong |
| 2025.915 | The "False-High" Transferrin Saturation Phenotype: A Retrospective Review of Elevated TSAT Driven by Hypotransferrinaemia in Peritoneal Dialysis Patients. | Dr. CHAN Anthony Ting Pong |
| 2016.496 | CCCTC-binding factor (CTCF) in hepatocellular carcinoma: functional characterization of its role in tumorigenesis and its potential in targeted therapy. | Dr. CHAN Anthony Wing Hung |
| 2016.278 | Functional role of the gluconeogenesis regulatory enzyme, fructose-1,6-bisphosphatase-1 (FBP1), in hepatocarcinogenesis |
Dr. CHAN Anthony Wing Hung 陳永鴻 |
| 2024.668 | Use of dextran and magnesium in thoracic paravertebral block for thoracic surgery - a case report | Dr. CHAN Anyon |
| 2024.268 | Single shot thoracic paravertebral block (TPVB) with dextran and magnesium compared to continuous TPVB in unilateral rib fracture - a randomised controlled non-inferiority trial | Dr. CHAN Anyon |
Page 45 of 288.